These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17363269)
1. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine. Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y; Horiuchi Y Biologicals; 2007 Oct; 35(4):259-64. PubMed ID: 17363269 [TBL] [Abstract][Full Text] [Related]
2. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines. Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190 [TBL] [Abstract][Full Text] [Related]
3. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines. Jensen SE; Illigen KE; Badsberg JH; Hasløv KR Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164 [TBL] [Abstract][Full Text] [Related]
4. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines. Jensen SE; Engelhart Illigen KE; Hasløv KR Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192 [TBL] [Abstract][Full Text] [Related]
5. Improved protocols for histamine sensitization testing of acellular pertussis vaccines. Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771 [TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test. Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049 [TBL] [Abstract][Full Text] [Related]
7. The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test. Hoonakker ME; Ruiterkamp N; Hendriksen CF Vaccine; 2010 Feb; 28(5):1347-52. PubMed ID: 19941995 [TBL] [Abstract][Full Text] [Related]
8. Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines. Gaines-Das R; Ochiai M; Douglas-Bardsley A; Asokanathan C; Horiuchi Y; Rigsby P; Corbel MJ; Xing DK Hum Vaccin; 2009 Mar; 5(3):166-71. PubMed ID: 18758243 [TBL] [Abstract][Full Text] [Related]
9. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor. Vuolo AM; Lustigman B Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test. Horiuchi Y; Takahashi M; Asada S; Ishida S Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458 [TBL] [Abstract][Full Text] [Related]
11. Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test. Hoonakker ME; Verhagen LM; van der Maas L; Sloots A; Hendriksen CFM Vaccine; 2017 Feb; 35(8):1152-1160. PubMed ID: 28129894 [TBL] [Abstract][Full Text] [Related]
12. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397 [TBL] [Abstract][Full Text] [Related]
13. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine. van Straaten-van de Kappelle I; van der Gun JW; Marsman FR; Hendriksen CF; van de Donk HJ Biologicals; 1997 Mar; 25(1):41-57. PubMed ID: 9167008 [TBL] [Abstract][Full Text] [Related]
14. A curious histamine-sensitizing activity shown by the newly-developed Japanese acellular pertussis vaccine. Iwasa S; Ishida S; Asakawa S; Akama K Dev Biol Stand; 1985; 61():453-60. PubMed ID: 3835082 [TBL] [Abstract][Full Text] [Related]
15. Workshop on Animal free Detection of Pertussis Toxin in Vaccines--Alternatives to the Histamine Sensitisation Test. Bache C; Hoonakker M; Hendriksen C; Buchheit KH; Spreitzer I; Montag T Biologicals; 2012 Jul; 40(4):309-11. PubMed ID: 22609106 [TBL] [Abstract][Full Text] [Related]
16. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220 [TBL] [Abstract][Full Text] [Related]
17. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan. Pichichero ME; Decker MD Biologicals; 2005 Mar; 33(1):59. PubMed ID: 15713557 [No Abstract] [Full Text] [Related]
18. Characterization of the carbohydrate binding and ADP-ribosyltransferase activities of chemically detoxified pertussis toxins. Oh H; Kim BG; Nam KT; Hong SH; Ahn DH; Choi GS; Kim H; Hong JT; Ahn BY Vaccine; 2013 Jun; 31(29):2988-93. PubMed ID: 23664992 [TBL] [Abstract][Full Text] [Related]
19. Potency assay and characterization of lymphocytosis promoting factor in whole cell and acellular pertussis vaccines. Tiru M; Falk A; Brym-Grynblat B; Pettersson IM Dev Biol Stand; 1991; 73():157-65. PubMed ID: 1778309 [TBL] [Abstract][Full Text] [Related]
20. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice. Wagner LD; Corvette LJ; Ngundi MM; Burns DL Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]